FDA — authorised 31 May 2019
- Application: ANDA210510
- Marketing authorisation holder: ABHAI LLC
- Status: supplemented
🇺🇸 Atovaquone Oral Suspension in United States
FDA authorised Atovaquone Oral Suspension on 31 May 2019
Marketing authorisation
Other Infectious Disease approved in United States
Frequently asked questions
Is Atovaquone Oral Suspension approved in United States?
Yes. FDA authorised it on 31 May 2019.
Who is the marketing authorisation holder for Atovaquone Oral Suspension in United States?
ABHAI LLC holds the US marketing authorisation.